{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:11:39Z","timestamp":1784283099399,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.taap.2023.116568","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T20:45:48Z","timestamp":1685133948000},"page":"116568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhibition of CDK9 exhibits anticancer activity in hepatocellular carcinoma cells via targeting ribonucleotide reductase"],"prefix":"10.1016","volume":"471","author":[{"given":"Jiunn-Chang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsang-Pai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tun-Sung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2023.116568_bb0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/282615a0","article-title":"Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line","volume":"282","author":"Aden","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.taap.2023.116568_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bph.12408","article-title":"Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor","volume":"171","author":"Albert","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2023.116568_bb0015","first-page":"2124","article-title":"Establishment of a continuously growing cell line from primary carcinoma of the liver","volume":"50","author":"Alexander","year":"1976","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.taap.2023.116568_bb0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jso.24086","article-title":"Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options","volume":"113","author":"Ang","year":"2016","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.taap.2023.116568_bb0025","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cell.2013.08.003","article-title":"An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules","volume":"154","author":"Basu","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.taap.2023.116568_bb0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg3967","article-title":"An ecosystem of cancer cell line factories to support a cancer dependency map","volume":"16","author":"Boehm","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.taap.2023.116568_bb0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/1568009620666200212124357","article-title":"CDK9: therapeutic perspective in HCC therapy","volume":"20","author":"Borowczak","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.taap.2023.116568_bb0040","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2023.116568_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2023.116568_bb0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.taap.2023.116568_bb0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.taap.2023.116568_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.taap.2023.116568_bb0065","doi-asserted-by":"crossref","first-page":"21374","DOI":"10.1038\/srep21374","article-title":"Clinical relevance of liver kinase B1(LKB1) protein and gene expression in breast cancer","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2023.116568_bb0070","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1038\/s41467-019-13528-0","article-title":"Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2023.116568_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2023.116568_bb0080","first-page":"1211","article-title":"Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex","volume":"3","author":"Chu","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.taap.2023.116568_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-019-1517-4","article-title":"Organization and regulation of gene transcription","volume":"573","author":"Cramer","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.taap.2023.116568_bb0090","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.taap.2023.116568_bb0095","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1007\/s00018-021-03878-8","article-title":"CDK9 keeps RNA polymerase II on track","volume":"78","author":"Egloff","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2023.116568_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106758","article-title":"SnapShot: TP53 status and macrophages infiltration in TCGA-analyzed tumors","volume":"86","author":"El-Arabey","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2023.116568_bb0105","first-page":"43","article-title":"Extralysosomal degradation of proteins","volume":"42","author":"Gacko","year":"1997","journal-title":"Rocz. Akad. Med. Bialymst."},{"key":"10.1016\/j.taap.2023.116568_bb0110","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.taap.2023.116568_bb0115","doi-asserted-by":"crossref","first-page":"10084","DOI":"10.1016\/j.biomaterials.2013.08.088","article-title":"Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.taap.2023.116568_bb0120","article-title":"Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis","volume":"96","author":"He","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.taap.2023.116568_bb0125","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/1078-0432.CCR-06-2218","article-title":"Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo","volume":"13","author":"Heidel","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2023.116568_bb0130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1101\/gad.244368.114","article-title":"CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma","volume":"28","author":"Huang","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.taap.2023.116568_bb0135","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1089\/dna.2019.4932","article-title":"Five core genes related to the progression and prognosis of hepatocellular carcinoma identified by analysis of a coexpression network","volume":"38","author":"Kong","year":"2019","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.taap.2023.116568_bb0140","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2023.116568_bb0145","doi-asserted-by":"crossref","first-page":"662","DOI":"10.5009\/gnl13392","article-title":"High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma","volume":"8","author":"Lee","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.taap.2023.116568_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.taap.2023.116568_bb0155","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2023.116568_bb0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.taap.2023.116568_bb0165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2023.116568_bb0170","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"Lopez-Terrada","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.taap.2023.116568_bb0175","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkaa968","article-title":"CellMiner cross-database (CellMinerCDB) version 1.2: exploration of patient-derived cancer cell line pharmacogenomics","volume":"49","author":"Luna","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2023.116568_bb0180","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41388-021-01681-0","article-title":"Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers","volume":"40","author":"Monsivais","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2023.116568_bb0185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","article-title":"Ribonucleotide reductases","volume":"75","author":"Nordlund","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.taap.2023.116568_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s13258-022-01351-9","article-title":"CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells","author":"Park","year":"2023","journal-title":"Genes Genom."},{"key":"10.1016\/j.taap.2023.116568_bb0195","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jconrel.2012.01.045","article-title":"Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth","volume":"159","author":"Rahman","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.taap.2023.116568_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nchembio.1986","article-title":"Correlating chemical sensitivity and basal gene expression reveals mechanism of action","volume":"12","author":"Rees","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.taap.2023.116568_bb0205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2005-871200","article-title":"Hepatocellular carcinoma: molecular pathways and new therapeutic targets","volume":"25","author":"Roberts","year":"2005","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.taap.2023.116568_bb0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.taap.2023.116568_bb0215","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1158\/1078-0432.CCR-09-2214","article-title":"Combined functional genome survey of therapeutic targets for hepatocellular carcinoma","volume":"16","author":"Satow","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2023.116568_bb0220","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","article-title":"Harnessing connectivity in a large-scale small-molecule sensitivity dataset","volume":"5","author":"Seashore-Ludlow","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.taap.2023.116568_bb0225","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1517\/14728222.2013.840293","article-title":"Targeting ribonucleotide reductase for cancer therapy","volume":"17","author":"Shao","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.taap.2023.116568_bb0230","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1159\/000526978","article-title":"Cyclin-dependent kinase 9 inhibition as a potential treatment for hepatocellular carcinoma","volume":"100","author":"Shao","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.taap.2023.116568_bb0235","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2023.116568_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186851","article-title":"Prognostic value of the overexpression of fatty acid metabolism-related enzymes in squamous cell carcinoma of the head and neck","volume":"21","author":"Su","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116568_bb0245","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian","year":"2015","journal-title":"Ann. Surg."},{"key":"10.1016\/j.taap.2023.116568_bb0250","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2023.116568_bb0255","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.taap.2023.116568_bb0260","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4161\/auto.25573","article-title":"A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy","volume":"9","author":"Wang","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2023.116568_bb0265","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/his.12562","article-title":"Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAF V600E expression in thyroid cancer","volume":"66","author":"Wang","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.taap.2023.116568_bb0270","article-title":"Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling","author":"Yao","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2023.116568_bb0275","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1080\/15548627.2021.2007027","article-title":"CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma","volume":"18","author":"Yao","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2023.116568_bb0280","first-page":"1913","article-title":"CDK inhibitors in cancer therapy, an overview of recent development","volume":"11","author":"Zhang","year":"2021","journal-title":"Am. J. Cancer Res."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23002077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23002077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:02:19Z","timestamp":1758574939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23002077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":56,"alternative-id":["S0041008X23002077"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116568","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of CDK9 exhibits anticancer activity in hepatocellular carcinoma cells via targeting ribonucleotide reductase","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116568"}}